Tag: COMPASS
AI model predicts immunotherapy response across cancer types
COMPASS, a pan-cancer foundation model, outperforms 22 methods across 16 clinical cohorts by analyzing tumor transcriptomes through immune concepts.
COMPASS model predicts immunotherapy outcomes across 33 cancer types
The pan-cancer foundation model outperforms 22 other methods and generalizes to treatments not seen during training.